Jeffrey Trigilio

Chief Financial Officer, Cullinan Oncology.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jul 14, 2026Other 103,906 shares of XOMA Royalty Corp⁴
Apr 20, 2026Exercised options 11,538 shares of XOMA Royalty Corp⁵
Apr 13, 2026Shares withheld for tax 1,632 shares at $36.76 of XOMA Royalty Corp⁶
Apr 13, 2026Exercised options 4,000 shares of XOMA Royalty Corp⁶
Mar 11, 2026Granted 90,000 shares of XOMA Royalty Corp⁷
Feb 22, 2024Granted 50,000 shares of Cullinan Oncology³
Dec 21, 2023Sold 1,920 shares at $8.50 of Cullinan Oncology⁸
Dec 18, 2023Sold 398 shares at $8.22 of Cullinan Oncology⁹
Dec 12, 2023Sold 1,926 shares at $7.81 of Cullinan Oncology¹⁰
Jun 30, 2023Granted 2,340 shares at $9.08 of Cullinan Oncology¹¹
Jun 20, 2023Sold 399 shares at $12.94 of Cullinan Oncology¹²
Jun 12, 2023Sold 319 shares at $13.11 of Cullinan Oncology¹³
May 18, 2023Sold 399 shares at $8.76 of Cullinan Oncology¹⁴
May 12, 2023Sold 347 shares at $8.78 of Cullinan Oncology¹⁵
Apr 18, 2023Sold 398 shares at $10.71 of Cullinan Oncology¹⁶
Apr 12, 2023Sold 318 shares at $10.22 of Cullinan Oncology¹⁷
Mar 20, 2023Sold 399 shares at $11.32 of Cullinan Oncology¹⁸
Feb 17, 2023Granted 47,000 shares of Cullinan Oncology¹⁹
Dec 30, 2022Granted 201 shares at $8.97 of Cullinan Oncology²⁰
Jun 30, 2022Granted 1,451 shares at $10.90 of Cullinan Oncology²¹
Feb 11, 2022Granted 37,500 shares of Cullinan Oncology²²
Oct 15, 2021Sold 8,000 shares at $25.00 of Cullinan Oncology²³
Oct 15, 2021Exercised options 8,000 shares at $4.30 of Cullinan Oncology²³

The numbers on this page point here. Each one links to the record it came from.